Senate ends debate on FDA reauthorization bill

The vote was 89-3 on the motion to end debate on the Food and Drug Administration Safety and Innovation ACt (S. 3187).

A week earlier the House approved the bill and sent the amended version back to the Senate.

The legislation reauthorizes certain FDA programs and expands a user-fee program in order to speed up the FDA's approval process for certain drug and medical device applications.

Sens. Richard BurrRichard BurrOvernight Cybersecurity: Hackers hit Brexit petition Senate Intel leader: ISIS using encrypted apps to plan attacks Gun-control supporters plan next steps versus NRA MORE (R-N.C.), Rand PaulRand PaulTrump flexes new digital muscle Republicans question Trump's trip to Scotland Hate TV customer service? So does your senator MORE (R-Ky.) and Bernie SandersBernie SandersSanders's Nevada director floated two-sided coins for tiebreaks: report Overnight Finance: McConnell tees up Puerto Rico vote | Britain's credit rating slashed | Clinton vows to appoint trade prosecutor The Trail 2016: Warren takes VP batting practice MORE (I-Vt.) voted against the motion to end debate.

More in Senate

Dems end Senate takeover after nearly 15 hours

Read more »